The Bott Cancer Center at Holy Redeemer Hospital is proud to provide advanced cancer care to our patients and community by offering a variety of cancer clinical trials. Cancer clinical trials are research studies in which people and health care professionals work together to improve cancer care. They provide answers to scientific questions and help to find better ways to prevent, diagnose, or treat cancer. People who choose to take part in cancer clinical trials have an opportunity to contribute to the advancement of cancer care, while receiving the latest treatment options from clinical experts.

Holy Redeemer’s Institutional Review Board (IRB) supports the cancer clinical trials program by reviewing each clinical trial to ensure the study is conducted fairly and the rights and welfare of volunteer participants are protected. Holy Redeemer’s IRB is made up of doctors, researchers, nurses, pharmacists, local leaders, and other members of the community who are committed to our goal to provide the highest quality of care to our community.

As a member of the Penn Cancer Network, Holy Redeemer is able to provide access to trials sponsored by the National Cancer Institute. In addition, through the membership with the Abramson Cancer Center at the University of Pennsylvania, we are able to provide access to select National Institute of Health supported clinical trials that have been developed by researchers at Penn.

Clinical trials are completely voluntary; participation is a personal decision that should be made by each individual in conjunction with their physician and family. Please speak with your doctor to find out if a clinical trial is right for you or your loved one.

If you are interested in learning more about clinical trials at the Bott Cancer Center, please speak with your doctor or call our Clinical Trials Office at 215-938-3551.